Anxa1 Antibody

中文名稱：

Anxa1兔多克隆抗體
貨號：

CSB-PA001836HA01MO
規格：

￥440
圖片：
Western blot
All lanes: Anxa1 antibody at 12µg/ml
Lane 1: K562 whole cell lysate
Lane 2: Hela whole cell lysate
Lane 3: HepG2 whole cell lysate
Secondary
Goat polyclonal to rabbit IgG at 1/10000 dilution
Predicted band size: 39 kDa
Observed band size: 39 kDa
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

產品名稱：

Rabbit anti-Mus musculus (Mouse) Anxa1 Polyclonal antibody
Uniprot No.：

P10107
基因名：

Anxa1
別名：

Anxa1 antibody; Anx1 antibody; Lpc-1 antibody; Lpc1Annexin A1 antibody; Annexin I antibody; Annexin-1 antibody; Calpactin II antibody; Calpactin-2 antibody; Chromobindin-9 antibody; Lipocortin I antibody; Phospholipase A2 inhibitory protein antibody; p35 antibody
宿主：

Rabbit
反應種屬：

Mouse, Human
免疫原：

Recombinant Mouse Annexin A1 protein (2-346AA)
免疫原種屬：

Mus musculus (Mouse)

標記方式：

Non-conjugated

本頁面中的產品，Anxa1 Antibody (CSB-PA001836HA01MO)，的標記方式是Non-conjugated。對于Anxa1 Antibody，我們還提供其他標記。見下表：

標記方式	貨號	產品名稱	應用
HRP	CSB-PA001836HB01MO	Anxa1 Antibody, HRP conjugated	ELISA
FITC	CSB-PA001836HC01MO	Anxa1 Antibody, FITC conjugated
Biotin	CSB-PA001836HD01MO	Anxa1 Antibody, Biotin conjugated	ELISA

克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
產品提供形式：

Liquid
應用范圍：

ELISA, WB

推薦稀釋比：

Application	Recommended Dilution
WB	1:500-1:2000

Protocols：

ELISA Protocol
Western Blotting (WB) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Plays important roles in the innate immune response as effector of glucocorticoid-mediated responses and regulator of the inflammatory process. Has anti-inflammatory activity. Plays a role in glucocorticoid-mediated down-regulation of the early phase of the inflammatory response. Promotes resolution of inflammation and wound healing. Functions at least in part by activating the formyl peptide receptors and downstream signaling cascades. Promotes chemotaxis of granulocytes and monocytes via activation of the formyl peptide receptors. Contributes to the adaptive immune response by enhancing signaling cascades that are triggered by T-cell activation, regulates differentiation and proliferation of activated T-cells. Promotes the differentiation of T-cells into Th1 cells and negatively regulates differentiation into Th2 cells. Has no effect on unstimulated T-cells. Promotes rearrangement of the actin cytoskeleton, cell polarization and cell migration. Negatively regulates hormone exocytosis via activation of the formyl peptide receptors and reorganization of the actin cytoskeleton. Has high affinity for Ca(2+) and can bind up to eight Ca(2+) ions. Displays Ca(2+)-dependent binding to phospholipid membranes. Plays a role in the formation of phagocytic cups and phagosomes. Plays a role in phagocytosis by mediating the Ca(2+)-dependent interaction between phagosomes and the actin cytoskeleton.
基因功能參考文獻：
1. ANXA1 is a novel GnRH target gene in gonadotropes. ANXA1 also may be a target of local GnRH in peripheral tissues and may have a different role than that of ANXA5 PMID: 29213013
2. ANXA1 can be phosphorylated by PKC and is subsequently translocated to the nucleus of BV-2 microglial cells after oxygen glucose deprivation/reoxygenation, resulting in the induction of pro-inflammatory cytokines. PMID: 27426034
3. Our data indicate that hepatic overexpression of ANX1 and ANX2 inhibits APAP-induced expansion of liver injury PMID: 27451051
4. The present findings shed light on the role of GILZ in the mechanism of induction of Anxa1 by GCs. As Anxa1 is an important protein for the resolution of inflammatory response, GILZ may represent a new pharmacologic target for treatment of inflammatory diseases. PMID: 28373208
5. these data indicate that AnxA1 is actively expressed during L. braziliensis infection. PMID: 28289158
6. Data, including data from studies using knockout mice, suggest cAMP-elevating agents increase levels of AnxA1; this is involved in role of cAMP in resolving acute inflammation (here, ability of cAMP-elevating agents to treat LPS-induced neutrophilic pleurisy). These results reinforce hypothesis that AnxA1 acts in multiple cell types (neutrophils, macrophages) and at multiple levels to promote resolution of inflammation. PMID: 28655761
7. confirmed the ability of Plg/Pla to both promote efferocytosis and override the prosurvival effect of LPS via annexin A1. PMID: 28320709
8. this study shows that AnxA1 plays a crucial role in the context of acute gouty inflammation by promoting timely resolution of inflammation PMID: 27995621
9. Suggest protective role for Annexin A1 in arterial neointima formation in atherosclerosis-prone mice. PMID: 28062503
10. ANXA1 restores Abeta42-induced blood brain barrier disruption through inhibition of RhoA-ROCK signaling pathway PMID: 27633771
11. It is proposed that the interactions between ANXA1 and GATA-3 may provide clues to understand the immunosuppression and have potential as new therapeutic targets in immunotherapy after sepsis. PMID: 27833268
12. AnxA1, is related to the efficiency of the infliximab treatment in experimental colitis, constituting a potential biomarker of therapeutic efficacy PMID: 27343762
13. these data highlight AnxA1 as a novel determinant of neutrophil maturation and the mechanisms behind blood neutrophil homing to BM via the CXCL12/CXCR4 pathway. PMID: 26892496
14. We conclude that ANX-A1 is an important regulator of mast cell reactivity to compound 48/80 exerting a negative feedback effect through a mechanism that depends at least partly on the FPR receptor PMID: 26803520
15. muscle-contraction-induced calpain-dependent ANXA1 fragmentation has a wound-healing effect on damaged cells. This suggested that not the intact form but rather fragmented ANXA1 is a contraction-induced myokine PMID: 26458561
16. Annexin A1 Deficiency does not Affect Myofiber Repair but Delays Regeneration of Injured Muscles PMID: 26667898
17. Data show that endothelial annexin A1 from apolipoprotein AI knockout mice was decreased in comparison to that from wild type mice. PMID: 27012521
18. Anxa1 mRNA and protein is highly expressed in mesenchymal stromal cells (MSCs). Anxa1 KO MSCs cannot enhance glucose stimulated islet insulin secretion. PMID: 26470781
19. pan antagonist of AnxA1 receptors exacerbated the colitis outcome in TNFR1-/- mice, supporting the pivotal role of AnxA1 in the early recovery PMID: 26386311
20. knock-out mice are more susceptible to Mycobacterium tuberculosis infection PMID: 25533809
21. critical regulator of Th17 cell driven autoimmune diseases such as uveitis PMID: 25619792
22. annexin A1- formyl peptide receptor 2 pathway mediated the insulin resistance of skeletal muscle, as well as systemic insulin sensitivity. PMID: 25616869
23. Functional role of ANXA1 in tumorigenesis was established in invasion assay where knocking down ANXA1 in murine mammary tumor cell line 168FARN showed lower invasive capability. PMID: 25124533
24. AnxA1 and Fpr2 have a critical role in the manifestation of adrenal insufficiency in this LPS-induced model, through regulation of cholesterol ester storage PMID: 25818588
25. The annexin A1 fragment Ac2-26 counteracts conformational activation and clustering of integrins on myeloid cells evoked by CCL5, CCL2, and CXCL1 through inhibiting activation of the small GTPase Rap1. PMID: 25520364
26. these data indicate that annexin1 is essential in immunity to Mtb infection and mediates the power of DC efferocytosis and cross-presentation. PMID: 25562320
27. Data (including data from knockout mice) suggest that mobilization of neutrophils during stress requires expression of ANXA1 and activation of glucocorticoid receptor in neutrophils. PMID: 25184992
28. AnxA1 participates in a paradigm in which malignant prostate epithelial cells that are not cancer stem cells are induced to gain cancer stem cell-like properties. PMID: 24464914
29. These data show a multiantibody composition in lupus nephritis, where IgG2 autoantibodies against alpha-enolase and annexin AI predominate in the glomerulus and can be detected in serum. PMID: 24790181
30. findings identify ANXA1 as a proinvasive protein in melanoma that holds promise as a potential prognostic marker and therapeutic target PMID: 24997993
31. Macrophage-derived AnxA1 plays a functional role in modulating hepatic inflammation and fibrogenesis during nonalcoholic steatohepatitis progression. PMID: 24668763
32. Data (including data from knockout mice) suggest AnxA1 limits inflammatory response in central (cerebral cortex) and peripheral (mesenteric) microvasculature; estrogen acts independent of AnxA1 to protect cerebral but not mesenteric microvasculature. PMID: 22897118
33. Data show an increase of extracellular Annexin A1 (ANXA1) starting from the initial phases of skeletal muscle cell differentiation. PMID: 23144744
34. AX1 can exert diverse, fusogen-specific effects on cell-cell fusion, functioning as an extracellular mediator of differentiation-dependent membrane fusion or as an intracellular promoter of postfusion pore expansion and syncytium formation. PMID: 24648446
35. The present studies tested the hypothesis that neonatal hyperoxic exposure induces deficits in CCSP expression that are associated with persistent alterations in lung SCGB and ANXA1 expression. PMID: 24187664
36. ANXA1 plays an important role in TLR activation, leading to an augmentation in the type 1 IFN antiviral cytokine response. PMID: 24048896
37. In mice, annexin 1 prevented the development of inflammatory dendritic cells and suppressed the cellular immune response against the model antigen ovalbumin expressed in apoptotic cells. PMID: 23638088
38. we suggest that MIF counter-regulates Dexamethasone-induced annexin 1 expression PMID: 23777345
39. Results indicate that the AnxA1/FPR2 system has an important role in effecting the resolution of cerebral inflammation in sepsis and may provide a novel therapeutic target. PMID: 22964301
40. T-cell-expressed AnxA1 functions to attenuate T-cell-driven inflammatory responses via T-cell-intrinsic effects on intracellular signaling, proliferation, and Th1/Th17 cytokine release. PMID: 23267026
41. revealed annexin A1 to be an effective regulator in tumor stroma and suggested a mechanism that annexin A1 affects tumor development and metastasis PMID: 23077482
42. ANXA1(-/-) mice exhibit significantly increased BBB permeability as a result of disrupted interendothelial cell tight junctions, essentially related to changes in the actin cytoskeleton, which stabilizes tight and adherens junctions. PMID: 23277546
43. a novel epithelial FPR1/NOX1-dependent redox signaling pathway that promotes mucosal wound repair. PMID: 23241962
44. data raise the possibility that a reduction in plasma AnxA1 may contribute to the chronic inflammatory phenotype observed in human obesity PMID: 23038751
45. The data showed that annexin A1 exerts an inhibitory effect on COX-2 expression in the macula densa. ANXA1 may be a novel intrinsic modulator of renal juxtaglomerular regulation by inhibition of PGE2 synthesis. PMID: 22791338
46. Data suggest that Annexin 1 (ANXA1) plays a protective role in DNA damage and modulates cell adhesion and motility, indicating its potential role in cancer initiation as well as progression in breast carcinoma. PMID: 22511458
47. AnxA1 is an endogenous determinant for the therapeutic efficacy of Dexamethasone in inflammatory arthritis. PMID: 22562975
48. AnxA1 mediates natural and glucocorticoid-induced resolution of inflammation with profound effects on neutrophil apoptosis. PMID: 22493082
49. Cleavage of ANXA1 during mast-cell activation causes proinflammatory reactions by increasing the phosphorylation of cytosolic phospholipase A2 (cPLA2) and production of eicosanoids. PMID: 22539796
50. ANXA1 is an important regulatory factor in the development of allergic disease and dysregulation of its expression can lead to pathological changes which may affect disease progression. PMID: 22092555
顯示更多

收起更多
亞細胞定位：

Nucleus. Cytoplasm. Cell projection, cilium. Basolateral cell membrane. Lateral cell membrane. Cell membrane; Peripheral membrane protein. Apical cell membrane. Membrane; Peripheral membrane protein. Early endosome. Cytoplasmic vesicle membrane; Peripheral membrane protein. Endosome membrane; Peripheral membrane protein. Secreted. Secreted, extracellular space. Cell membrane; Peripheral membrane protein; Extracellular side. Secreted, extracellular exosome. Cytoplasmic vesicle, secretory vesicle lumen. Cell projection, phagocytic cup.
蛋白家族：

Annexin family
組織特異性：

Detected in lung. Detected at the apical membrane of airway epithelial cells. Detected in intestinal epithelial cells. Detected in skeletal muscle. Detected in prostate. Detected in thymus (at protein level). Detected in stomach, lung, spleen, ovary and u
數據庫鏈接：

KEGG: mmu:16952

STRING: 10090.ENSMUSP00000025561

UniGene: Mm.248360

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human